324 related articles for article (PubMed ID: 15660243)
1. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
Pfitzer T; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
[TBL] [Abstract][Full Text] [Related]
2. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
[TBL] [Abstract][Full Text] [Related]
3. The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.
Niederhoffer N; Schmid K; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):434-43. PubMed ID: 12709782
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart.
Szabo B; Nordheim U; Niederhoffer N
J Pharmacol Exp Ther; 2001 May; 297(2):819-26. PubMed ID: 11303075
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoids on adrenaline release from adrenal medullary cells.
Niederhoffer N; Hansen HH; Fernandez-Ruiz JJ; Szabo B
Br J Pharmacol; 2001 Nov; 134(6):1319-27. PubMed ID: 11704653
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
Niederhoffer N; Szabo B
J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
[TBL] [Abstract][Full Text] [Related]
8. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
Toczek M; Schlicker E; Grzęda E; Malinowska B
Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
[TBL] [Abstract][Full Text] [Related]
9. Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats.
Pfitzer T; Niederhoffer N; Szabo B
Br J Pharmacol; 2004 Jul; 142(6):943-52. PubMed ID: 15226190
[TBL] [Abstract][Full Text] [Related]
10. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats.
Godlewski G; Malinowska B; Schlicker E
Br J Pharmacol; 2004 Jun; 142(4):701-8. PubMed ID: 15159284
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
Shimizu T; Yokotani K
Eur J Pharmacol; 2008 Mar; 582(1-3):62-9. PubMed ID: 18234185
[TBL] [Abstract][Full Text] [Related]
13. A search for presynaptic beta3-adrenoceptors in the rat.
Zelaszczyk D; Zakrzeska A; Kwolek G; Malinowska B; Schlicker E
Fundam Clin Pharmacol; 2005 Apr; 19(2):147-53. PubMed ID: 15810894
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.
Freiman I; Szabo B
Neuroscience; 2005; 133(1):305-13. PubMed ID: 15893652
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
16. Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex.
Kovacs FE; Knop T; Urbanski MJ; Freiman I; Freiman TM; Feuerstein TJ; Zentner J; Szabo B
Neuropsychopharmacology; 2012 Apr; 37(5):1104-14. PubMed ID: 22048459
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Hampson RE; Miller F; Palchik G; Deadwyler SA
Neuropharmacology; 2011 May; 60(6):944-52. PubMed ID: 21288475
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
19. Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
Kushmerick C; Price GD; Taschenberger H; Puente N; Renden R; Wadiche JI; Duvoisin RM; Grandes P; von Gersdorff H
J Neurosci; 2004 Jun; 24(26):5955-65. PubMed ID: 15229243
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
